Back
ImmunityBio, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40
IBRX
ImmunityBio, Inc.
Last Price:
$6.02
Seasonality Move:
-11.09%
7 Day Trial
ALL ACCESS PASS
$
7
ImmunityBio, Inc. Stock Forecast
-
Over the next 52 weeks, ImmunityBio, Inc. has on average historically risen by 74.5% based on the past 10 years of stock performance.
-
ImmunityBio, Inc. has risen higher in 4 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
-
Is ImmunityBio, Inc. Stock Undervalued?The current ImmunityBio, Inc. [IBRX] share price is $5.95. The Score for IBRX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
IBRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will ImmunityBio, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, ImmunityBio, Inc. has on average historically risen by 74.5% based on the past 10 years of stock performance.
ImmunityBio, Inc. Stock Rating
Sell
40
ImmunityBio, Inc. (IBRX)
is a Sell
Is ImmunityBio, Inc. overpriced?
-
ImmunityBio, Inc. has risen higher in 4 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
ImmunityBio, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
immunitybio.com
52-Week Data
52-Week High:
8.28
52-Week Low:
1.83
Prediction Charts
Market Cap:
5.9B
Price in USD:
5.95
Volume:
39.4M
Beta:
1.42
Technical Analysis
SMA50:
3.89
SMA100:
3.12
SMA200:
2.87
52-Wk Change:
79.07%
Stock Predictions
-
Is ImmunityBio, Inc. stock public?Yes, ImmunityBio, Inc. is a publicly traded company.
-
What is the ImmunityBio, Inc. stock quote today?The ImmunityBio, Inc. stock price is 5.95 USD today.
-
How to buy ImmunityBio, Inc. stock online?You can buy ImmunityBio, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-27 | 5.96 | 5.95 | 6.13 | 5.59 |
| Jan-28 | 6.01 | 6.15 | 6.29 | 5.54 |
| Jan-29 | 6.15 | 5.91 | 6.35 | 5.73 |
| Jan-30 | 5.78 | 6.25 | 6.47 | 5.67 |
| Feb-2 | 6.29 | 6.13 | 6.75 | 5.93 |
| Feb-3 | 6.15 | 6.33 | 6.54 | 5.95 |
| Feb-4 | 6.29 | 5.88 | 6.29 | 5.69 |
| Feb-5 | 5.72 | 5.64 | 5.98 | 5.58 |
| Feb-6 | 5.70 | 6.05 | 6.08 | 5.61 |
| Feb-9 | 6.05 | 6.93 | 7.03 | 5.82 |
| Feb-10 | 6.95 | 6.56 | 7.14 | 6.55 |
| Feb-11 | 6.72 | 6.54 | 6.77 | 6.28 |
| Feb-12 | 6.53 | 6.62 | 6.87 | 6.40 |
| Feb-13 | 6.62 | 5.95 | 7.30 | 5.94 |
ImmunityBio, Inc. Earnings
ImmunityBio, Inc. Earnings Report: Per Share ImmunityBio, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
ImmunityBio, Inc. Forecast Revenue Growth
ImmunityBio, Inc. Stock Analysis: Historical quarterly revenues per share for ImmunityBio, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and an increase next year of $0.27 per share.
* ImmunityBio, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.